| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1291439 | B | Displacement of [125I]MCP1 from human CCR2 after 30 mins by gamma counter | Homo sapiens | 14 | ALA1287724 | single protein format | Scientific Literature | |
| 2. | ALA1291440 | B | Displacement of [125I]MCP1 from mouse CCR2 after 30 mins by gamma counter | Mus musculus | 8 | ALA1287724 | single protein format | Scientific Literature | |
| 3. | ALA1291441 | F | Antagonist activity at human CCR2 assessed as inhibition of MCP1 induced chemotaxis after 30 mins | Homo sapiens | 6 | ALA1287724 | assay format | Scientific Literature | |
| 4. | ALA1291442 | F | Antagonist activity at mouse CCR2 assessed as inhibition of MCP1 induced chemotaxis after 30 mins | Mus musculus | 6 | ALA1287724 | assay format | Scientific Literature | |
| 5. | ALA1291443 | A | Protein binding in human serum assessed as unbound fraction | Homo sapiens | 5 | ALA1287724 | cell-free format | Scientific Literature | |
| 6. | ALA1291444 | A | Protein binding in mouse serum assessed as unbound fraction | Mus musculus | 5 | ALA1287724 | cell-free format | Scientific Literature | |
| 7. | ALA1291445 | B | Inhibition of human ERG | Homo sapiens | 5 | ALA1287724 | single protein format | Scientific Literature | |
| 8. | ALA1291446 | B | Inhibition of rat CCR2 | Rattus norvegicus | 1 | ALA1287724 | single protein format | Scientific Literature | |
| 9. | ALA1291447 | B | Inhibition of cynomolgus CCR2 | Cylas formicarius | 1 | ALA1287724 | single protein format | Scientific Literature | |
| 10. | ALA1291448 | B | Inhibition of mouse CCR1 | Mus musculus | 1 | ALA1287724 | single protein format | Scientific Literature | |
| 11. | ALA1291449 | B | Inhibition of mouse CCR5 | Mus musculus | 1 | ALA1287724 | single protein format | Scientific Literature | |
| 12. | ALA1291450 | A | Clearance in CD-1 mouse at 5 mg/kg, iv | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 13. | ALA1291451 | A | Volume of distribution at steady state in CD-1 mouse at 5 mg/kg, iv | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 14. | ALA1291452 | A | Half life in CD-1 mouse at 5 mg/kg, iv | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 15. | ALA1291453 | A | Cmax in CD-1 mouse at 10 mg/kg, po | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 16. | ALA1291502 | A | AUC in CD-1 mouse at 10 mg/kg, po | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 17. | ALA1291503 | A | Oral bioavailability in CD-1 mouse at 10 mg/kg, po | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 18. | ALA1291504 | A | Cmax in BALB/c mouse at 10 mg/kg, po | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 19. | ALA1291505 | A | AUC in BALB/c mouse at 10 mg/kg, po | Mus musculus | 1 | ALA1287724 | organism-based format | Scientific Literature | |
| 20. | ALA4495582 | F | SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate | Severe acute respiratory syndrome coronavirus 2 | 7,212 | ALA4495564 | assay format | SARS-CoV-2 Screening Data 2020-21 |
The page will load shortly, Thanks for your patience!